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Background:To evaluate the effectiveness of the ViabahnOpen Revascularization Technique (VORTEC) in the treatment
of thoracoabdominal aortic aneurysms (TAAAs) and pararenal aortic aneurysms (PAAAs) by hybrid procedures.
Methods:BetweenDecember 2004 andMarch 2009, 58 patients (45male, mean age, 74 years) were diagnosed with TAAA
(n  30) and PAAA (n  28) and treated electively by combined hybrid techniques. Hybrid procedure includes bypass
surgery of the visceral and renal arteries (debranching or rerouting), followed by endovascular exclusion of the aortic
aneurysm. One hundred thirteen renovisceral vessels were revascularized in a retrograde fashion (ie, 98 renal and 15
visceral arteries), using VORTEC. The novel technique consists of the placement of self-expanding stent-grafts (Viabahn
graft, Gore and Associates, Flagstaff, Ariz) in Seldinger technique into the renal and visceral arteries after surgical
identification of the origin of the arteries. The end of the stent outside of the renal artery was sutured end to side directly
with the main feeding graft, bypassing the aneurysm, or was fixed into an interposition branch graft on the main bypass.
All cases were treated by two-staged approach (endovascular aneurysm repair [EVAR] performed after recovery from the
debranching procedure). Computed tomography angiography and clinical follow-up were obtained before discharge, at
six weeks, and three, six, and 12 months after the procedure and then annually.
Results: Primary technical success of VORTEC was achieved in all patients. Overall primary patency rate of the novel
technique was 97% during a mean follow-up of 22.1  12.9 months (range, 1-52 months); the primary patency of the
subgroups PAAAs and TAAAs was 97.7% and 96.4%, respectively; the assisted primary patency rate was 98%, as two
occluded Viabahn grafts were reopened by thrombolysis and thrombus aspiration. No patient required long-term
hemodialysis. Thirty-day mortality rate was 8.6% (5/58) and 25.8% (15/58) for the entire follow up. Permanent
neurologic deficit occurred in two cases (3.4%; paraplegia, n 1; paraparesis, n 1). The overall endoleak rate was 17.1%
as three patients presented early (30-day) type I endoleak, treated by cuff-implantation, and six patients presented type
II endoleak, three of them treated by coil embolization of the patent vessel and the others treated conservatively with
radiological surveillance.
Conclusion: VORTEC allows performance of easy, safe, and minimally invasive revascularization of renal and visceral
arteries and may represent a significant technical advance in the hybrid repair of TAAAs and PAAAs. However, the
questions of reproducibility by other centers and long-term results are mandatory to establish this alternative revascu-
larization option. (J Vasc Surg 2009;50:1280-4.)Treatment of thoracoabdominal-(TAAAs) and parare-
nal aortic aneurysms (PAAAs) is challenging due to involve-
ment of renovisceral vessels or proximal extensiveness up to
the origin of the renals, leaving no place for infrarenal aortic
clamping. Despite the development of many surgical strat-
egies,1 the operative mortality across the United States is
greater than commonly reported in the literature based on
the International Classification of Diseases, Ninth Revision,
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1280Clinical Modification (ICD-9-CM)2 and mandates a re-
examination of the treatment strategies.
Procedures to treat TAAAs and PAAAs with endovas-
cular devices remain in their infancy. Large experiences are
limited for the moment to a few centers worldwide. In
particular, the need for customized devices results in a delay
in treatment and is associated with complicated device
sizing and procedural planning.
In contrast to the total endovascular approach, hybrid
open-endovascular procedures are readily available and repro-
ducible, avoiding aortic cross-clamping and two cavities tho-
racoabdominal approach.However, any conclusion about the
effectiveness of the treatment based on the published cases3
remains, for themoment, premature; the combined approach
is time consuming with a significant number and technically
demanding anastomoses to the renovisceral vessels tending to
bypass-related complications and failures.
Recently, we published a novel technique (VORTEC)4
using self-expanding stent-grafts to facilitate renal artery
revascularization, reducing the duration of flow inter-
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of the present study is the early and mid-term outcome anal-
ysis of VORTEC in patients who suffered from TAAA and
PAAA treated by combined open-endovascular repair.
METHODS
This was a single-center (Zurich University Hospital)
series of 58 consecutive patients with TAAA and PAAA
who underwent an elective hybrid procedure, including at
least one renovisceral revascularization with VORTEC,
between December 2004 and March 2009. Thirty patients
(51.7%) presented with a TAAA, and 28 (48.3%) with a
PAAA (20 suprarenal, 8 juxtarenal AAA). Data were pro-
spectively collected in an in-hospital registry and retrospec-
tively reviewed. Informed consent (treatment type, anony-
mous data analysis, and publication of results) of the patient
or relatives (in patients already intubated) was obtained in
all cases. All survivors were surveyed in our outpatient’s
clinic and our follow-up data (including followup imaging)
were sent for review.
Demographics. Mean patient age was 74 years (range
64 to 89). Thirteen patients (22.4%) were women. The
patients were all classified as high-risk for conventional
open surgical repair. This category included patients with
serious cardiovascular comorbidities (more than three; such
as COPD, congestive heart failure, and coronary artery
occlusive disease); American Society of Anesthesiologists
(ASA) score of 3 or more; previous myocardial infarction;
coronary stent or bypass; redo cases (thoracic and/or ab-
dominal aortic repair). Patients= comorbidities and aneu-
rysms characteristics are shown in Tables I and II.
Preoperative investigations. All patients underwent
a contrast enhanced computed tomography angiography
(CTA) of the heart5 and in case of significant coronary
disease, a myocardial scinigraphy to detect myocardial per-
fusion was also performed preoperatively. Coronary angio-
gram was performed in patients with known history of
angina pectoris or when myocardial scintigraphy was
pathologic. CTA of the neck, chest, abdomen, and pelvis
was obtained in all to study aortic pathology and to delin-
eate visceral and renal morphology and iliofemoral anat-
Table I. Patient comorbidities and risk factors
TAAA
group
PAAA
group P
Arterial hypertension 26/30 17/28 .221
Nicotine abuse 26/30 22/28 .421
Diabetes mellitus 11/30 12/28 .234
Mean age 74.2 74.0 .219
Previous aortic surgery, myocardial
infarction, coronary stent, or bypass 10/30 10/28 .185
Cardiac insufficiency (NYHA  1) 14/30 12/28 .122
ASA  3 or more 23/30 21/28 .211
ASA, American Society of Anaesthesiologists; PAAA, pararenal aortic aneu-
rysms; NYHA, New York Heart Association; TAAA, thoracoabdominal
aortic aneurysm.omy.In order to estimate the pre-and postoperative renal
function, glomerular filtration rate was calculated, the size
of the kidney was measured by ultrasound, and parenchy-
mal artery resistance index of the kidneys was calculated.
A totally endovascular approach (branched or fenes-
trated stent graft implantation) was not considered in these
patients mostly due to anatomical limitations (hostile anat-
omy such as tortuosity of the access vessels and/or aorta,
dissection, combined disease of the iliac, thoracoabdominal
aorta and arch, narrowed aortic lumen excluding endolu-
minal navigation) and lack of availability of customized
branched device in the acute setting at our institution for
the symptomatic patients. Another possible treatment op-
tion of PAAA by chimney grafts6 needs to be evaluated
regarding endoleak rate, fraction, or collapse of the grafts in
the long term.
Patients with ruptured PAAAs and TAAAs who under-
went a hybrid procedure by VORTEC were excluded from
our study due to limited survival rate of these patients
caused by several clinical entities such as multiorgan failure,
systemic inflammatory response syndrome, and shock.
These conditions can not allow clinical evaluation of the
performance of VORTEC.
Surgical techniques. Bypass procedure: All cases were
performed under general anaesthesia, with the patient in a
supine position. Renovisceral vessels were exposed through
a transperitoneal (n 51) or retroperitoneal approach (n
7), described by Ljungman et al.7 The choice of inflow site
for retrograde visceral and/or renal artery blood feeding
graft was determined for each patient individually based on
review of preoperative CTA scan. In most cases, a single
10-mm graft served for the renovisceral arteries. In some
cases, two separate 8-mm to 10-mm grafts or a bifurcated
graft were used.
Viabahn Open Revascularization TEChnique
(VORTEC). The technique has already been described by
our group.4 Briefly, after puncturing the arterial wall (renal
artery, superior mesenteric artery, celiac trunk), the Via-
bahn (Viabahn Graft; Gore and Associates, Flagstaff, Ariz)
Table II. Aneurysm characteristics
Aneurysm PAAA TAAA P
Symptomatic 3 6 .234
Asymptomatic 25 24 .342
Degenerative 16 30 .321
Secondary 12 0 .256
TAAA type I 3
TAAA type II 5
TAAA type III 9
TAAA type IV 13
Diameter (cm) 7.1  1.1 7.25  0.8 .221
Total 28 30
Degenerative origin, Atherosclerotic etiology; PAAA, pararenal aortic aneu-
rysm; Secondary, after previous abdominal or thoracic aortic surgery; TAAA,
thoracoabdominal aortic aneurysm; TAAA I-IV, based on the Crawford
classification.was introduced over a guidewire using the Seldinger tech-
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artery and partly projecting outside the artery, the graft was
balloon dilated and two polypropylene 6.0 sutures were
placed to fix the stent graft within the recipient artery. The
end of the stent graft outside of the target artery was
sutured end to side directly with the main graft (polytetra-
fluoroethylene [PTFE] 7 mm or 8 mm of diameter), (only
one anastomosis necessary), or was deployed in an end to
end fashion either into an interposition graft originating
from the main feeding graft or from the aorta. Finally, in
the majority if the cases, the proximal stump of the target
arteries was ligated to avoid retrograde perfusion of the
aneurysm.
The morphological criteria to perform VORTECwere:
diameter of the renal or superior mesenteric artery4 mm;
existence of landing zone of1 cm; and absence of relevant
branches of the artery in the landing zone. Due to the
flexibility of the self-expanding stent graft, kinking or cal-
cification of the artery were not considered as contraindi-
cations. The insertion and deployment of the covered
stents is possible only through antegrade access, which is
amenable in the renal and superior mesenteric artery using
median laparatomy. In case of revascularization of celiac
trunk, antegrade access is possible only by retroperitoneal
exposure of the vessel.
Access site complications include: hematoma; arterial
occlusion/thrombosis; severe vasospasm; intimal injury/
dissection; pseudoaneurysm; AV fistula; vascular perfora-
tion or rupture; and arterial embolization at punctured site.
Endovascular aortic aneurysm repair procedure.
The stentgrafts were deployed with standard endovascular
techniques in a sequential, reversed trombone technique
beginning distally with the smallest diameter. Four com-
mercially available stent grafts (Excluder and TAG, W. L.
Gore and Associates, Flagstaff, Ariz; Evita Jotec, Hechin-
gen, Germany; and Zenith Cook, Inc., Bloomington, Ind)
were used; they were tailored and sized individually based
on preoperative CT imaging. A mean of three stent grafts
(median; range 1-5) were implanted in each patient.
Neuroprotective management. Neuroprotective man-
agement consisted basically of maintenance of stable intra-
operative hemodynamics and target hematocrit value of
above 30% during endovascular aneurysm repair (EVAR).
Systolic blood pressure was maintained above 120 mm Hg
after stentgraft deployment, to increase collateral blood
flow to the spinal anterior artery. Three patients developed
delayed paraparesis postoperatively, which was successfully
reverted by a combination therapy of immediate infusion of
Mannitol, blood pressure increase, and blood transfusion
to achieve a hematocrit value of 30%.
Postoperative anticoagulation. Early postoperative
anticoagulation consisted of intravenous administration of
heparin (full heparinization/24 hours) combined with 100
mg aspirin; long-term therapy included warfarin combined
with aspirin (100 mg daily) or dual-antiplatelet therapy
with aspirin (100 mg daily) and clopidogrel (75 mg daily).
Follow up. Length of follow up was a mean of 22.1
12.9 months (range, 1-51 months) and completed for allpatients. CTA and clinical follow up were obtained at six
weeks and three, six, and 12 months after the procedure
and then annually.
Statistical analysis. Statistical analysis was performed
with SPSS (SPSS Inc, Chicago, Ill). Continuous data were
compared by using the Student t test and categorical vari-
ables with the Fisher exact test as appropriate. The three-
year primary patency rates were estimated by using the
Kaplan-Meier lifetable analysis. Patency was reported for
the grafts performed.
RESULTS
The aneurysms characteristics and types are shown in
Table II. Overall, 98 renal arteries and 15 visceral arteries
were revascularized by VORTEC. The mean operation
time for the renovisceral revascularization was 4.9  1.2
hours, and for the endovascular approach, 3.2 1.4 hours
for the retrograde revascularization, and 1.2  0.4 hours
for the endovascular part. The mean time of ischemia was
11 minutes for the end to side VORTEC technique and 2
minutes for the further deployed VORTEC technique with
deployment directly into the interposition graft. For the
patients with patent viabahn grafts in the follow up, no
evidence of microalbuminuria or pathological proteinuria
were found and the postoperative parenchymal artery resis-
tance index kidney was normal. The technical success of the
suggested technique was 100% (58/58).
Morbidity/mortality. Overall 30-day mortality rate
was 8.6% (5/58). Thirty-day mortality rate of the elective
patients was 6.1% (3/49) and of the symptomatic patient
group was 22.2% (2/9), respectively. Overall mortality was
25.8% (15/58). The causes related to mortality for each
subgroup are shown in Table III. In total, two patients
(3.4%) developed permanent neurological deficit such as
paraplegia (n  1) and paraparesis (n  1).
The endoleak rate was 17.1% (ie, three patients devel-
oped early [30-day] type I endoleak) and endoleak was
treated by cuff-implantation. Six patients showed type II
endoleak, three of them treated by coil embolization of the
patent vessel (lumbal artery and inferior mesenteric artery)
and the others conservatively with radiological surveillance.
Patency. The primary cumulative patency rate of the
viabahns after a median follow up of 22.1  12.9 months
was 97% (Fig). Especially for the two subgroups of our
study, primary patency rate for the patients with TAAA was
96.4% (mean follow up of 24.6 12.5 months) and for the
patients with PAAA 97.7% (mean follow-up of 24.6 12.5
months), respectively. Secondary patency rate was 98%, as
two Viabahn stent-grafts could be reopened by thrombol-
ysis and successful thrombus aspiration. No patient needed
long-term dialysis.
DISCUSSION
Despite the improvement of surgical techniques and
strategies to avoid neurological complications in cases of
TAAA and transdiaphragmatic repair, two cavities surgery
continues to be hazardous. Rigberg et al8 presented their
lar co
doane
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31% mortality at one year for the elective procedures.
The present study represents the largest single-center
experience in the current literature regarding elective hy-
brid open endovascular treatment of 58 consecutive high-
risk patients with TAAA or PAAA. In order to simplify the
technically demanding access to the renovisceral arteries by
performing a conventional surgical anastomosis, we used a
novel anastomosis-technique with endografts4 and at-
temped to evaluate its utility of patients with TAAAs and
PAAAs. In accordance with the published literature-review
analysis regarding hybrid procedures in the thoracoab-
dominal aorta,3 we confirmed the feasibility of the com-
Table III. Early (30 days) and total mortality for the pa
treated by hybrid approach
n Type of aneurysm Death
1 TAAA type IV 30 d
2 TAAA type IV 30 d
3 TAAA type III 30 d
4 TAAA type IV 30 d
5 Sec. PAAA 30 d
6 TAAA type IV 4 mo
7 TAAA type II 2 mo
8 TAAA type III 3 mo
9 TAAA type II 5 mo
10 Sec. PAAA 9 mo
11 Sec. PAAA 3 mo
12 TAAA type III 2 mo
13 PAAA 2 mo
14 TAAA type IV 2 mo
15 PAAA 2 mo
ARDS, Acute respiratory distress syndrome; DIC, disseminated intravascu
aneurysm; Secondary PAAA, previous open aortic repair and proximal pseu
Fig. Primary cumulative patency rate of the Viabahns endopros-
theses in patients with thoracoabdominal and juxtarenal aortic
aneurysms over a mean follow up period of 22.1  12.9 months.bined techniques in the treatment of TAAA and PAAA,avoiding extensive thoracotomy and two cavities surgery in
more than 50 patients.
On the other hand, total endovascular approach with
fenestrated and side-branched modular endograft systems
need, for the moment, further technical practice and learn-
ing curve. A number of series have been published descri-
bing the results of endovascular repair of TAAAs with
existing risk for death, paraplegia, and renal failure.7-10 The
main weakness of the technique remains the delay of at least
six to eight weeks between evaluation and treatment due to
the fact that these highly customized devices cannot be kept
in inventory.
The hybrid techniques described so far aim to be a
reliable alternative for high-risk patients who are unfit for
two cavities open repair. The avoidance of an extensive
thoracotomy and aortic cross-clamping, especially in pa-
tients with previous operations and hostile abdomen, may
be beneficial, but it has to be proven and for the moment
the results are disillusioning.11 The remarkable number of
bypass anastomoses and retrograde revascularization from the
distal aorta or iliac vessels remains the Achilles heel of the
procedure. In particular, the bypass to the mesenteric artery
through a retropancreatic access tends to fail and is linked to
severe complications such as intestinal ischemia or acute pan-
creatitis with consecutive multiple organ failure.
Replacing the conventional surgical anastomosis to the
renovisceral arteries by VORTEC, the suggested technique
may represent a relevant improvement over the traditional
vascular anastomotic surgical techniques for renal artery or
visceral revascularization, as part of the combined proce-
dures. The technique may play a significant contribution in
the evolution of the hybrid procedures reducing the expo-
sure and dissection of the target vessel to a minimum
(anterior wall only) and interrupting the blood flow only
for a very short time. The suggested approach of the renal
arteries aims to simplify the very often technically demand-
s with thoracoabdominal and juxtarenal aortic aneurysm
Etiology Symptomatology
ARDS no
Pulmonary embolism yes
Intestinal ischemia no
DIC, uncontrolled bleeding no
ARDS yes
DIC no
MOFS no
ARDS no
Staphylococcus sepsis no
MOFS no
Intestinal ischemia no
MOFS no
Intestinal ischemia no
Intestinal ischemia no
Aneurysm rupture prior EVAR no
agulopathy; MOFS, multiorgan failure syndrome; PAAA, pararenal aortic
urysm; TAAA, thoracoabdominal aortic aneurysm.tienting renal artery revascularization of extensive TAAAs and
JOURNAL OF VASCULAR SURGERY
December 20091284 Donas et alPAAAs and to reduce the big number of the anastomoses in
the combined procedures, which are time-consuming and
complication-related.
Moreover, the suggested advance in the hybrid repair
creates a quasi end to end manner renal artery revascular-
ization, which leads to less blood turbulence than an end-
to-side anastomosis with the renal artery. Graft fixation
with two polypropylene 6-0 sutures seems to be safe and
secure, avoiding clamping-related events. In addition, the
absence of severe impairment of the renal function with
long-term hemodialysis emphasizes the perspective and
value of the suggested technique and the need for further
evaluation and development. The mid-term patency rate of
this novel approach of the renovisceral arteries is promising
and underscores the effectiveness of the suggested tech-
nique. In addition, no intimal dissection, injury of the
revascularized vessel, or arterial embolization due to punc-
ture of the vessel wall occurred.
Concerning the anticoagulation regimen, no random-
ized data are available. Based on our clinical practice, intra-
venous administration of heparin combined with 100 mg
aspirin and was preferred directly postoperatively. Early and
long-term therapy included warfarin combined with aspirin
or dual-antiplatelet therapy with aspirin and clopidogrel.
The absence of thrombotic deposits within the implanted
renovisceral stentgrafts on CTA follow-ups and the very
low occlusion rate might be explained by the effectiveness
of our anticoagulation regimen.
CONCLUSIONS
Hybrid open endovascular repair of TAAAs and PAAAs
is a valuable treatment option of patients unfit for open
reconstruction. However, numerous anastomoses are nec-
essary, making the procedure time-consuming and techni-
cally demanding. The novel VORTEC is a reliable alterna-
tive anastomosis technique helping to overcome hazardous
conventional anastomoses in this clinical entity. The mid-
term outcome of this new approach in a large number of
more than 50 patients with TAAA and PAAA is very
encouraging and underscores the utility of the presented
technique simplifying the retrograde renovisceral revascu-
larization of combined procedures. However, further eval-
uation is warranted.
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